Peptilogics
Peptilogics is dedicated to revolutionizing the discovery process for novel peptide therapeutics aimed at treating serious and life-threatening diseases. By leveraging the potential of peptide biology and advanced machine learning techniques, the company is transforming drug design and development, focusing on precision engineering to create next-generation medicines.
Peptilogics
2681 Sidney Street, Pittsburgh, PA 15203
What We Do
An investigational antibiotic peptide candidate for the treatment of periprosthetic joint infection (PJI), demonstrating potent in vitro and nonclinical activity with an acceptable safety profile in Phase I studies.